MWR
RDY icon

McAdams Wright Ragen’s Dr. Reddy's Laboratories RDY Stock Holding History

McAdams Wright Ragen’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25,525
Closed -$220K – 438
2014
Q2 		$220K Buy
25,525
+900
+4% +$7.57K 0.01% 355
2014
Q1 		$216K Sell
24,625
-1,000
-4% -$8.7K 0.01% 336
2013
Q4 		$210K Buy
+25,625
New +$203K 0.01% 338

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

McAdams Wright Ragen's RDY Position: Q3 2014 in Review

McAdams Wright Ragen sold out of Dr. Reddy's Laboratories (RDY) in Q3 2014, closing a stake of 25,525 shares — an estimated $220K sold.

McAdams Wright Ragen first reported a position in RDY in Q4 2013 and held it in 3 quarters. The position peaked at $220K in Q2 2014. 159 funds tracked by Wall St. Rank hold RDY as of Q3 2014.

  • McAdams Wright Ragen reported no remaining Dr. Reddy's Laboratories position as of Q3 2014 after selling out during the quarter.
  • McAdams Wright Ragen sold 25,525 Dr. Reddy's Laboratories shares in Q3 2014, an estimated $220K.
  • McAdams Wright Ragen first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 3 quarters.
  • McAdams Wright Ragen's Dr. Reddy's Laboratories position peaked at $220K in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.